| First Author | Gao SQ | Year | 2023 |
| Journal | iScience | Volume | 26 |
| Issue | 4 | Pages | 106488 |
| PubMed ID | 37091229 | Mgi Jnum | J:349823 |
| Mgi Id | MGI:7658010 | Doi | 10.1016/j.isci.2023.106488 |
| Citation | Gao SQ, et al. (2023) Thrombospondin1 mimics rapidly relieve depression via Shank3 dependent uncoupling between dopamine D1 and D2 receptors. iScience 26(4):106488 |
| abstractText | Deficits in astrocyte function contribute to major depressive disorder (MDD) and suicide, but the therapeutic effect of directly reactivating astrocytes for depression remains unclear. Here, specific gains and losses of astrocytic cell functions in the medial prefrontal cortex (mPFC) bidirectionally regulate depression-like symptoms. Remarkably, recombinant human Thrombospondin-1 (rhTSP1), an astrocyte-secreted protein, exerted rapidly antidepressant-like actions through tyrosine hydroxylase (Th)/dopamine (DA)/dopamine D2 receptors (D2Rs) pathways, but not dopamine D1 receptors (D1Rs), which was dependent on SH3 and multiple ankyrin repeat domains 3 (Shank3) in the mPFC. TSP1 in the mPFC might have potential as a target for treating clinical depression. |
